IPO
IPO
Best Performers
Forthcoming Issues
Closed Issues
New Listings
Current Issues
IPO Performance
IPO News
IPO Analysis
Basis of Allotment
Draft Prospectus
  HOME  >  IPO  >   IPO SNAPSHOT
IPO Snapshot    
Rossari Biotech Ltd.
Issue Open Date 13-Jul-20  
Issue Closing Date 15-Jul-20  
Application Money 100  
Allotment Money  
Price Band 423 - 425  
Minimium Application No. 35  
Issue Size (Shares) 11682020  
Market Lot 1.00  
Objective
The net proceeds of the Fresh Issue, i.e. Gross proceeds of the Fresh Issue less the Offer Expenses apportioned to our Company (“Net Proceeds”) are proposed to be utilised in the following manner:1. Repayment/prepayment of certain indebtedness availed by our Company (including accrued interest);2. Funding working capital requirements; and3. General corporate purposes.
Category No. of Shares No. of Shares Subscription Ratio
  Offered / Reserved Bid For  
Non-Institutional Investors   1751471   420059220   239.83  
Qualified Institutional Buyers   2335294   199114615   85.26  
Retail Individual Investors   4086765   29559810   7.23  
Business Description
Promoter's Holding
Total Share Capital   48400000  
Offered to Public    
Promoter's Holding (Pre-Issue)   100  
Promoter's Holding (Post-Issue)    
Address
201 A - B
2nd Floor
Akruti Corporate Park
L. B. S. Marg
Next To Ge Gardens
Kanjurmarg (W)
Mumbai ,
Maharashtra ,
400078
Phone: 022 61233800
Email: info@rossarimail.com
Website: www.rossari.com
Registrar
Link Intime India Pvt Ltd.
C 101
247 Park
LBS Marg
Vikhroli (West)
Mumbai
Listed at
BSE, NSE
Lead Manager
Axis Capital Ltd.
ICICI Securities Ltd
Promoters
Edward Walter Menezes
Sunil Srinivasan Chari
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Awareness & Information | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.